Fundalysisby DARKHORSESTOCKS

Fund manager · HDFC

Nikhil Mathur

Runs 1 scheme worth ₹3,501 Cr.

  • Fund house

    HDFCThey run their schemes at HDFC.

  • AUM they run

    ₹3,501 CrThe AUM of the schemes they run, as main or co-manager, at the latest month's end, as AMFI reports it. A scheme two people run counts for both.

  • Schemes

    1 now · 1 beforeSchemes they run now, as main or co-manager, and ones they ran before, since Sept 2024.

  • Experience

    Not publishedTheir fund house's documents give no figure for it yet.

Profile

About

Their fund house's documents give no profile for them yet.

Schemes now1

  1. HDFC Pharma and Healthcare Fund₹3,501 Cr

AUM they run(Oct 2024 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20263,501−9.7%
Aug 20263,877+11.0%
Jul 20263,493+10.8%
Jun 20263,152+9.0%
May 20262,891+33.9%
Apr 20262,159+9.2%
Mar 20261,977−2.6%
Feb 20262,030+8.1%
Jan 20261,878−5.3%
Dec 20251,984−1.3%
Nov 20252,010+2.2%
Oct 20251,967+3.7%
AUM at month end, Sept 2026
₹3,501 Cr
+78.0% since Oct 2025
Fig. 1.The AUM of the schemes Nikhil Mathur ran at each month's end, each only in the months they ran it, ₹ crore. A scheme two people run counts in full for both. Source: AMFI.

Schemes over time(Oct 2023 – now)

  1. Pharma and Healthcare Fund
  2. MNC Fund
HDFC202420252026
Fig. 1.The schemes they ran when, the oldest first: each from the date its fund house gives, or the first document listing them where it gives none, to when they left, coloured by fund house.

Schemes(Oct 2023 – now)

HDFC

1 now · since Oct 2023
  1. HDFC Pharma and Healthcare Fund
    Fund managerOct 2023—3y 1m₹3,501 CrSectoral / ThematicTER 1.03%

Source.Each scheme's Scheme Summary Document at AMFI and its filings at NSE.

Performance(2 schemes)

Growth · Direct plans

Return as manager
+29.01%
Beat peers
1 of 1
vs peers
+16.41 pt
Longest run
3.0 years
Beat benchmark
Upcoming
Each scheme Nikhil Mathur ran, against its peers and benchmark over the same months. Source: AMFI. Click a column's header to sort by it.
HDFC Pharma and Healthcare Fund
Oct '23–now · 3.0y
+29.01%+12.60%+16.41 pt––
HDFC MNC Fund
May '26–Sep '26 · 0.3y
+7.34%+5.90%+1.44 pt––
Fig. 1.Each scheme Nikhil Mathur ran, against its peers and benchmark over the same months. Source: AMFI.